EA200500800A1 - QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS - Google Patents

QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS

Info

Publication number
EA200500800A1
EA200500800A1 EA200500800A EA200500800A EA200500800A1 EA 200500800 A1 EA200500800 A1 EA 200500800A1 EA 200500800 A EA200500800 A EA 200500800A EA 200500800 A EA200500800 A EA 200500800A EA 200500800 A1 EA200500800 A1 EA 200500800A1
Authority
EA
Eurasian Patent Office
Prior art keywords
het
alkyloxy
hydroxy
alkyl
hydrogen
Prior art date
Application number
EA200500800A
Other languages
Russian (ru)
Other versions
EA010601B1 (en
Inventor
Кунрад Йозеф Лодевейк Марсель Андрис
Анил Коул
Жером Эмиль Жорж Гийемон
Элизабет Тереза Жанна Паскье
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Priority to EA200500800A priority Critical patent/EA010601B1/en
Publication of EA200500800A1 publication Critical patent/EA200500800A1/en
Publication of EA010601B1 publication Critical patent/EA010601B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к применению соединения для изготовления лекарственного средства для лечения бактериальной инфекции, где указанное соединение является соединением формулыего фармацевтически приемлемой кислотно- или основно-аддитивной солью, его стереохимически изомерной формой или его N-оксидной формой, где Rпредставляет собой водород, галоген, полигалоСалкил, Cалкил, Ar или Het; p представляет собой целое число, равное 1 или 2; Rпредставляет собой Cалкилокси, СалкилоксиСалкилокси или Cалкилтио; Rпредставляет собой Ar, Het или Het; Rи Rпредставляют собой, каждый независимо, водород, Cалкил или бензил; или Rи Rвместе с атомом N, к которому они присоединены, могут образовывать радикал, выбранный из группы пирролидинила, 2-пирролинила, 3-пирролинила, пирролила, имидазолидинила, пиразолидинила, 2-имидазолинила, 2-пиразолинила, имидазолила, пиразолила, триазолила, пиперидинила, пиридинила, пиперазинила, пиридазинила, пиримидинила, пиразинила, триазинила, морфолинила и тиоморфолинила, каждое из указанных колец может быть, необязательно, замещено Cалкилом, галогеном, полигалоСалкилом, гидрокси, гидроксиСалкилом, Cалкилокси, амино, моно- или ди(Cалкил)амино, Cалкилтио, СалкилоксиСалкилом, СалкилтиоСалкилом или пиримидинилом; Rпредставляет собой водород, галоген, полигалоСалкил, Cалкил, Cалкилокси, Cалкилтио или два вицинальных радикала Rмогут быть взяты вместе с образованием двухвалентного радикала формулы -СН=СН-СН=СН-; r представляет собой целое число, равное 1 или 2; Rпредставляет собой водород, Cалкил, Ar, Het или Het; при условии, что бактериальная инфекция является другой, чем микобактериальная инфекция.The present invention relates to the use of a compound for the manufacture of a medicament for the treatment of a bacterial infection, where said compound is a compound of the pharmaceutically acceptable acid or base addition salt, its stereochemically isomeric form or its N-oxide form, where R is hydrogen, halogen, polyhaloalkyl C1-6 alkyl, Ar or Het; p is an integer equal to 1 or 2; R 1 is C 1-6 alkyloxy, C 1-6 alkyloxy C 1-6 alkyloxy or C 1-6 alkylthio; R4 is Ar, Het or Het; R1 and R4 are each independently hydrogen, C1-6 alkyl or benzyl; or R together with the atoms N, to which they are attached may form a radical selected from the group of pyrrolidinyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrrolyl, imidazolidinyl, pyrazolidinyl, 2-imidazolinyl, 2-pyrazolinyl, imidazolyl, pyrazolyl, triazolyl, piperidinyl , pyridinyl, piperazinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, morpholinyl and thiomorpholinyl, each of these rings can be optionally substituted by C1-6alkyl, halogen, polyhaloxy4alkyl, hydroxy, hydroxy C1-6alkyloxy, amino, monocyan or polyacetate, polyhydroxyalkyl, hydroxy, hydroxy C1-6 l) amino, alkylthio, SalkiloksiSalkilom, SalkiltioSalkilom or pyrimidinyl; R 1 is hydrogen, halogen, polyhaloalkyl, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio or two vicinal radicals R3 can be taken together to form a bivalent radical of the formula -CH = CH-CH = CH-; r is an integer equal to 1 or 2; R4 is hydrogen, C1-6 alkyl, Ar, Het or Het; provided that the bacterial infection is other than mycobacterial infection.

EA200500800A 2005-06-09 2005-06-09 Quinoline derivatives as antibacterial agents EA010601B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA200500800A EA010601B1 (en) 2005-06-09 2005-06-09 Quinoline derivatives as antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA200500800A EA010601B1 (en) 2005-06-09 2005-06-09 Quinoline derivatives as antibacterial agents

Publications (2)

Publication Number Publication Date
EA200500800A1 true EA200500800A1 (en) 2006-12-29
EA010601B1 EA010601B1 (en) 2008-10-30

Family

ID=40851968

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500800A EA010601B1 (en) 2005-06-09 2005-06-09 Quinoline derivatives as antibacterial agents

Country Status (1)

Country Link
EA (1) EA010601B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
CA2318842A1 (en) * 1998-01-26 1999-07-29 Julie Dorothy Warrack Quinoline derivatives as antibacterials
EP1527050B1 (en) * 2002-07-25 2010-04-07 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Also Published As

Publication number Publication date
EA010601B1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
JO2977B1 (en) Quinoline derivatives as antibacterial agents
CR20210001A (en) 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases
EA200800501A1 (en) QUINOLINE DERIVATIVES AS ANTIBACTERIAL MEANS
NO20090580L (en) Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
BRPI0510560A (en) substituted pyrido [2,3-d] pyrimidin-7-ones and their derivatives as therapeutic agents
EP3693369A3 (en) Bromodomain inhibitors
NO20090581L (en) Hydroxylated and methoxylated cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
MX2010004491A (en) Pyridine and pyrazine derivatives - 083.
NO20081026L (en) Quinoline derivatives as antibacterial agents
CY1112247T1 (en) KINOLIN PRODUCTS FOR THE THERAPEUTIC TREATMENT OF TREATMENT
TW200630374A (en) Thiazolyldihydroindazoles
TW200801018A (en) 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors
WO2022038365A3 (en) Fumarate derivatives and their medical use
NO20081068L (en) Quinoline derivatives as antibacterial agents
ME01484B (en) Quinoline derivatives as antibacterial agents
TW200635592A (en) Pyridyl-substituted spiro-hydantoin compounds and use thereof
NO20080481L (en) Quinoline derivatives as antibacterial agents
MX2019004375A (en) Bromodomain inhibitors.
EA200500800A1 (en) QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
TW200716109A (en) Quinoline derivatives as antibacterial agents
MY163500A (en) Quinoline derivatives as antibacterial agents

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM